Budesonide 17,21-Diacetyloxy Impurity

Product Description
CAT No.
ALN-B022018
CAS No.
17652-24-3
Mol. F.
C25H32O7
Mol. Wt.
444.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 2-((8S,9S,10R,11S,13S,14S,17R)-17-Acetoxy-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
Smiles : O=C([C@]([C@]12C)(CC[C@@]1([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C2)OC(C)=O)COC(C)=O
Inchi : InChI=1S/C23H28O5/c1-13(24)28-12-20(27)18-7-6-17-16-5-4-14-10-15(25)8-9-22(14,2)21(16)19(26)11-23(17,18)3/h7-10,16-17,19,21,26H,4-6,11-12H2,1-3H3/t16-,17-,19-,21+,22-,23-/m0/s1
Technical Data
Reference
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461
RFQ